| Literature DB >> 28579985 |
Dafne Pérez-Montarelo1, Esther Viedma1, Mercedes Murcia1, Irene Muñoz-Gallego1, Nieves Larrosa2, Patricia Brañas1, Nuria Fernández-Hidalgo3, Joan Gavaldà3, Benito Almirante3, Fernando Chaves1.
Abstract
Staphylococcus aureus is a major cause of bacteremia and, even with appropriate clinical management, causes high morbidity, and mortality due to its involvement in endovascular complications and metastatic infections. Through different pathogenic in vivo and in vitro models we investigated the behavior of S. aureus most relevant clonal complexes (CCs) causing endovascular complications. We analyzed 14 S. aureus strains representing CC5, CC8, CC15, CC30, and CC45 that caused endovascular complications, including methicillin susceptible and resistant isolates and strains with different functionality of the agr global regulator. Their adherence to collagen, interaction with the endothelium, resistance to immune attack, capacity to form biofilm and virulence in the Galleria mellonella model were analyzed. CC30 and CC45 showed greater adhesion to collagen and CC8 showed a trend towards higher rate of intracellular persistence in endothelial cells. All CCs exhibited similar tolerance to neutrophil antimicrobial peptide hNP-1 and were capable of forming biofilms under static conditions. The virulence assay in the G. mellonella model demonstrated that CC15 and CC30 were the most and least virulent, respectively. The analysis of the genomic sequences of the most relevant virulence genes identified some CC15 specific gene patterns (absence of enterotoxins and sak gene) and variants (mainly in leucocidins and proteases), but did not reveal any gene or variant that could be responsible for the increased virulence detected for CC15 strains. Even though all the CCs were capable of causing endovascular complications, our results showed that different CCs are likely to produce these complications through different mechanisms which, if confirmed in more sophisticated models, would indicate the need to more specific management and therapeutic approaches.Entities:
Keywords: Staphylococcus aureus; clonal complex; endovascular complications; virulence
Year: 2017 PMID: 28579985 PMCID: PMC5437158 DOI: 10.3389/fmicb.2017.00917
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Main clinical and microbiological characteristics of the 14 selected .
| SA80001 | CA | Native mitral valve endocarditis | >3 days | Yes (CNS) | No | No | 30 | MSSA | Yes | 3 |
| SA107 | HCA | Catheter-related bacteremia | No | Yes (lung) | No | No | 30 | MSSA | No | 3 |
| SA123 | HCA | Native mitral valve endocarditis | No | Yes (thrombophlebitis) | Yes | No | 45 | MSSA | Yes | 1 |
| SA520 | HCA | Native mitral valve endocarditis | >3 days | – | No | No | 45 | MSSA | Yes | 1 |
| SA170015 | HCA | Prosthetic mitral valve endocarditis | No | No | No | No | 45 | MRSA | Yes | 1 |
| SA103 | HCA | Native mitral valve endocarditis | No | Yes (thrombophlebitis) | No | No | 5 | MSSA | Yes | 2 |
| SA80004 | HCA | Native mitral valve endocarditis | No | No | No | No | 5 | MSSA | No | 2 |
| SA170006 | HCA | Native aortic valve endocarditis | >3 days | Yes (liver, spleen, kidney) | No | No | 5 | MRSA | No | 2 |
| SA180009 | HCA | Prosthetic aortic valve endocartidis | >7 days | Yes (perivalvular abscess) | No | Yes | 5 | MRSA | Yes | 2 |
| SA10009 | CA | Native mitral valve endocarditis | No | No | No | No | 15 | MSSA | Yes | 2 |
| SA10014 | CA | Native aortic valve endocarditis | >7 days | Yes (spleen, kidney) | Yes | Yes | 15 | MSSA | Yes | 2 |
| SA180015 | CA | Prosthetic aortic & mitral valve endocarditis | No | Yes (perivalvular abscess) | No | No | 8 | MSSA | No | 1 |
| SA190006 | CA | Native aortic valve endocarditis | No | No | No | Yes | 8 | MSSA | Yes | 1 |
| SA70002 | HCA | Tricuspid endocarditis | >7 days | Yes (spondylodiscitis) | No | No | 8 | MRSA | No | 1 |
Klebsiella pneumoniae pulmonary infection. CC, clonal complex; MSSA, methicillin susceptible S. aureus; MRSA, methicillin resistant S. aureus; Agr, Accesory global regulator; CA, Community-associated; HCA, Healthcare-associated; CNS, central nervous system.
Figure 1Adherence to collagen. Adhesion percentage to collagen according to CC (A), agr functionality (B), and methicillin resistance (C). Bars and error bars represent the mean and standard deviation of at least 3 independent experiments. Only significant p-values are shown.
Figure 2Adhesion, invasion, and intracellular endothelial cells assay. Confluent endothelial cell obtained from umbilical cord veins were infected with 107 CFU and the percentage of bacterial cells able to adhere (A–C), invade (D–F) and persist intracellularly (G–I) is represented according CC, agr functionality and methicillin resistance. Results are expressed as the percentage of the initial inoculum recovered. Bars and error bars indicate the mean and standard deviations of at least three independent experiments. Only significant p-values are shown.
Figure 3Susceptibility to hNP-1. Susceptibility to hNP-1 of the different CCs (A), according to agr functionality (B), and methicillin resistance (C). The bars and error bars indicate the means and standard deviations for each group, respectively (at least three independent assays per strain). There are no statistically significant differences.
Figure 4Biofilm formation. Biofilm formation of the different CCs (A), according to agr functionality (B), and methicillin resistance (C). The bars and error bars indicate the means and standard deviations for each group, respectively (at least three independent assays per strain). Only significant p-values are shown.
Figure 5. Data from a minimum of three experiments per strain were plotted on Kaplan-Meier survival curves and a log-rank test was used to determine significance. All data grouped according to CC (A), agr functionality (B), and methicillin resistance (C). The number of larvae included in each group is indicated (n). Significance is indicated with asterisks, *p < 0.001.
Virulence genes distribution of the 14 analyzed strains.
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | – | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | – | 1 | 1 | – | – | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | – | 1 | 1 | – | – | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | – | 1 | 1 | – | – | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | – | 1 | 1 | 1 | – | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | – | 1 | 1 | – | – | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | – | 1 | 1 | – | – | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | – | 1 | 1 | – | – | 1 | 1 | 1 | 1 | 1 | |
| – | – | – | – | – | – | – | – | – | – | – | 1 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 1 | – | – | |
| – | – | – | – | – | – | – | – | – | 1 | 1 | – | – | – | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | – | – | – | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | – | – | – | |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | – | – | – | – | – | |
| – | – | – | – | 1 | 1 | – | 1 | 1 | 1 | 1 | – | – | – | |
| 1 | 1 | 1 | 1 | 1 | 1 | – | – | – | – | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | – | – | – | – | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | – | – | – | – | 1 | 1 | 1 | 1 | |
1 indicates that the gene is present and – that it is absent in each particular strain.
Hlb truncated by Sa3int phage.
Virulence genes variants especifically detected in CC15 strains.
| AgrB | 1 | 889G>A | DQ157967 | |
| AgrD | 0 | – | – | DQ157967 |
| AgrC | 11 | – | 1739T>C; 1743A>G; 1754G>A; 1763C>T; 1769C>T; 1775A>G; 1787A>T; 1790T>C; 1793T>C; 1796T>C; 2030A>G | DQ157967 |
| AgrA | 5 | 2818A>G (136K>R) | 2801C>T; 2810G>A; 2813G>A; 2816T>A | DQ157967 |
| Rot | 1 | – | 126T>A | CP012692 |
| SarA | 0 | – | – | CP017094 |
| CodY | 0 | – | – | CP012409 |
| SarR | 0 | – | – | CP012409 |
| SaeR | 0 | – | – | CP016861 |
| SaeS | 0 | – | – | CP016856 |
| SrrA | 0 | – | – | CP012976 |
| SigB | 0 | – | – | CP015645 |
| Hla | 1 | 319C>T (107P>S) | – | LN626917 |
| Hld | 0 | – | – | DQ157967 |
| HlgB | 0 | – | – | CP012692 |
| HlgC | 1 | – | 925 G>A | CP012692 |
| HlgA | 0 | – | – | CP012692 |
| Psma1 | 0 | – | – | CP014444 |
| Psma2 | 0 | – | – | CP014444 |
| Psma3 | 0 | – | – | CP014444 |
| Psma4 | 0 | – | – | CP014444 |
| Psmb1 | 0 | – | – | CP014444 |
| Psmb2 | 0 | – | – | CP014444 |
| LukE | 3 | 734G>C (245G>A) | 9T>C; 672 G>A | CP012970 |
| LukD | 10 | – | 93 A>G; 189 G>T; 201 T>G; 219 C>T; 234 A>G; 246C>T; 249 A>T; 261A>T; 801 C>T; 921 C>T | CP012970 |
| Aur | 3 | – | 1187 C/A>G; 1208 A/T>C; 1322A>T | CP010402 |
| SplA | 9 | 10G>A (4G>S); 64A>G (22N>D); 70C>T (24P>S); 257C>T (86S>L); 527A>G (176D>G); 554G>A (185G>E) | 231T>C; 438T>C; 618T>C | CP012978 |
| SplB | 1 | – | 495 T>C | CP012978 |
| SplE | 1 | 551C>G (184A>G) | – | CP012978 |
| Scn | 0 | – | – | CP012120 |
| Chp | 2 | 315T>A (46M>L) | 256C>T | CP012120 |
Results from the comparison of CC15 only with CC45 (type II Agr).
Only detected in one of the two CC15 strains.